260 related articles for article (PubMed ID: 15077310)
1. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.
Theander E; Manthorpe R; Jacobsson LT
Arthritis Rheum; 2004 Apr; 50(4):1262-9. PubMed ID: 15077310
[TBL] [Abstract][Full Text] [Related]
2. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.
Theander E; Henriksson G; Ljungberg O; Mandl T; Manthorpe R; Jacobsson LT
Ann Rheum Dis; 2006 Jun; 65(6):796-803. PubMed ID: 16284097
[TBL] [Abstract][Full Text] [Related]
4. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
5. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992.
Martens PB; Pillemer SR; Jacobsson LT; O'Fallon WM; Matteson EL
J Rheumatol; 1999 Jun; 26(6):1296-300. PubMed ID: 10381046
[TBL] [Abstract][Full Text] [Related]
6. Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow up.
Theander E; Andersson SI; Manthorpe R; Jacobsson LT
J Rheumatol; 2005 Aug; 32(8):1495-502. PubMed ID: 16078325
[TBL] [Abstract][Full Text] [Related]
7. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
8. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort.
Lhatoo SD; Johnson AL; Goodridge DM; MacDonald BK; Sander JW; Shorvon SD
Ann Neurol; 2001 Mar; 49(3):336-44. PubMed ID: 11261508
[TBL] [Abstract][Full Text] [Related]
9. Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.
Goules AV; Tatouli IP; Moutsopoulos HM; Tzioufas AG
Arthritis Rheum; 2013 Nov; 65(11):2945-53. PubMed ID: 24166794
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.
Alamanos Y; Tsifetaki N; Voulgari PV; Venetsanopoulou AI; Siozos C; Drosos AA
Rheumatology (Oxford); 2006 Feb; 45(2):187-91. PubMed ID: 16332955
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren's syndrome.
Brito-Zerón P; Soria N; Muñoz S; Bové A; Akasbi M; Belenguer R; Sisó A; Ramos-Casals M
Semin Arthritis Rheum; 2009 Apr; 38(5):389-95. PubMed ID: 18378278
[TBL] [Abstract][Full Text] [Related]
12. Long-term cause-specific mortality among five-year survivors of childhood cancer.
Cardous-Ubbink MC; Heinen RC; Langeveld NE; Bakker PJ; Voûte PA; Caron HN; van Leeuwen FE
Pediatr Blood Cancer; 2004 Jun; 42(7):563-73. PubMed ID: 15127410
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
Fox RI; Dixon R; Guarrasi V; Krubel S
Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
[TBL] [Abstract][Full Text] [Related]
14. Perinatal characteristics and risk of developing primary Sjögren's syndrome: a case-control study.
Mostafavi B; Akyuz S; Jacobsson ME; Nilsen LV; Theander E; Jacobsson LH
J Rheumatol; 2005 Apr; 32(4):665-8. PubMed ID: 15801022
[TBL] [Abstract][Full Text] [Related]
15. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
[TBL] [Abstract][Full Text] [Related]
16. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
17. Causes of death in patients with celiac disease in a population-based Swedish cohort.
Peters U; Askling J; Gridley G; Ekbom A; Linet M
Arch Intern Med; 2003 Jul; 163(13):1566-72. PubMed ID: 12860579
[TBL] [Abstract][Full Text] [Related]
18. [Primary Sjögren's syndrome. A longitudinal study of 68 patients].
Botsios C; Ostuni P; Sfriso P; Grava C; Andretta M; Todesco S
Recenti Prog Med; 2001 Dec; 92(12):741-6. PubMed ID: 11822094
[TBL] [Abstract][Full Text] [Related]
19. Excess mortality among long-stay psychiatric patients in Northern Finland.
Räsänen S; Hakko H; Viilo K; Meyer-Rochow VB; Moring J
Soc Psychiatry Psychiatr Epidemiol; 2003 Jun; 38(6):297-304. PubMed ID: 12799779
[TBL] [Abstract][Full Text] [Related]
20. [Long term mortality of five-year survivors of childhood cancer in Rhône-Alpes region].
Trombert-Paviot B; Frappaz D; Casagranda L; Plantaz D; Bertrand Y; Stephan JL; Berger C; Freycon F
Rev Epidemiol Sante Publique; 2008 Dec; 56(6):383-90. PubMed ID: 19013040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
